The type IIB matrix model is a promising candidate for a nonperturbative formulation of superstring theory. As such, it is expected to explain the origin of space–time and matter at the same time. This has been partially demonstrated by the previous Monte Carlo studies on the Lorentzian version of the model, which suggested the emergence of (3+1)-dimensional expanding space–time. Here we investigate the same model by solving numerically the classical equation of motion, which is expected to be valid at late times since the action becomes large due to the expansion of space. Many solutions are obtained by the gradient descent method starting from random matrix configurations, assuming a quasi-direct-product structure for the (3+1)-dimensions and the extra 6 dimensions. We find that these solutions generally admit the emergence of expanding space–time and a block-diagonal structure in the extra dimensions, the latter being important for the emergence of intersecting D-branes. For solutions corresponding to D-branes with appropriate dimensionality, the Dirac operator is shown to acquire a zero mode in the limit of infinite matrix size.
The type IIB matrix model was proposed as a non-perturbative formulation of superstring theory in 1996. We simulate a model that describes the late time behavior of the IIB matrix model by applying the complex Langevin method to overcome the sign problem. We clarify the relationship between the Euclidean and the Lorentzian versions of the type IIB matrix model in a recently discovered phase. By introducing a constraint, we obtain a model where the spacetime metric is Euclidean at early times, whereas it dynamically becomes Lorentzian at late times.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.